WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,235 Cr | ₹887 Cr | ₹617 Cr | ₹-22 Cr | ₹261 Cr |
What is the latest Total Non-Current Liabilities ratio of WOCKHARDT ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹1,235 Cr |
| Mar2025 | ₹887 Cr |
| Mar2024 | ₹617 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹261 Cr |
How is Total Non-Current Liabilities of WOCKHARDT Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,235 Cr | 39.23 | |
| Mar2025 | ₹887 Cr | 43.76 | |
| Mar2024 | ₹617 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹261 Cr | - | |
Compare Total Non-Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹31,404.8 Cr | -4.5% | 6.7% | 25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -4.5% |
6.7% |
25.5% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses